Danaher's (DHR) Cepheid Received FDA Emergency Use Authorization for COVID-19 Assay, Cowen Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Danaher Corp. (NYSE: DHR) | Delayed: 232.63 +2.52 (1.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.11 | 52 Week High | $102.79 | |||
| Open | $235.33 | 52 Week Low | $75.71 | |||
| Day High | $236.67 | P/E | 61.22 | |||
| Day Low | $229.92 | EPS | $3.80 | |||
| Volume | 1,133,875 | |||||
